Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

Trials stopped early: too good to be true?

Pocock S, White I.

Lancet. 1999 Mar 20;353(9157):943-4. No abstract available.

PMID:
10459899
2.

[Liver transplantation for hepatocellular carcinoma].

Tanaka A, Tanaka K, Kaihara S, Ueda M, Uemoto S, Kiuchi T, Egawa H.

Nihon Rinsho. 2001 Oct;59 Suppl 6:705-16. Review. Japanese. No abstract available.

PMID:
11762042
3.

Treatment of recurrent hepatocellular carcinoma after liver transplantation.

Davis E, Wiesner R, Valdecasas J, Kita Y, Rossi M, Schwartz M.

Liver Transpl. 2011 Oct;17 Suppl 2:S162-6. doi: 10.1002/lt.22361. Review. No abstract available.

4.
5.

Tools for monitoring patients with hepatocellular carcinoma on the waiting list and after liver transplantation.

Kneteman N, Livraghi T, Madoff D, de Santibañez E, Kew M.

Liver Transpl. 2011 Oct;17 Suppl 2:S117-27. doi: 10.1002/lt.22334. Review. No abstract available.

6.

Design and endpoints of clinical trials in hepatocellular carcinoma.

Llovet JM, Di Bisceglie AM, Bruix J, Kramer BS, Lencioni R, Zhu AX, Sherman M, Schwartz M, Lotze M, Talwalkar J, Gores GJ; Panel of Experts in HCC-Design Clinical Trials.

J Natl Cancer Inst. 2008 May 21;100(10):698-711. doi: 10.1093/jnci/djn134. Epub 2008 May 13. Review.

PMID:
18477802
7.

Should the liver transplant criteria for hepatocellular carcinoma be different for deceased donation and living donation?

Grant D, Fisher RA, Abecassis M, McCaughan G, Wright L, Fan ST.

Liver Transpl. 2011 Oct;17 Suppl 2:S133-8. doi: 10.1002/lt.22348. Review. No abstract available.

8.

[Strategy to improve the prognosis of liver transplantation for hepatocellular carcinoma].

Fan J, Xu Y.

Zhonghua Wai Ke Za Zhi. 2008 Nov 1;46(21):1602-5. Review. Chinese. No abstract available.

PMID:
19094749
9.

Indications and limitations of liver transplantation for hepatocellular carcinoma.

Wudel LJ Jr, Chapman WC.

Surg Oncol Clin N Am. 2003 Jan;12(1):77-90, ix. Review.

PMID:
12735131
10.

[Hepatic transplantation for hepatocellular carcinoma: state of the art].

Lerut J.

J Chir (Paris). 2007 Mar-Apr;144(2):105-10. Review. French.

PMID:
17607224
11.

[Treatment of hepatocellular carcinoma: hepatic resection and liver transplantation].

Cenuşă A.

Rev Med Chir Soc Med Nat Iasi. 2005 Oct-Dec;109(4):709-12. Review. Romanian.

PMID:
16610164
12.

[Hepatic resections for hepatocarcinoma in the XXI century].

Ramacciato G, Mercantini P, Nigri G, Giaccaglia V, Dente M, Del Gaudio M, Lauro A, Ercolani G, Pinna AD.

Minerva Chir. 2008 Feb;63(1):45-60. Review. Italian.

PMID:
18212727
13.

[Phases 0, 1 and 2 oncology clinical trials: current questions].

Penel N, Fournier C, Stéphanie C.

Bull Cancer. 2010 Jan;97(1):55-63. doi: 10.1684/bdc.2010.1016. Review. French.

14.

Immunosuppression and hepatocellular carcinoma.

Schlitt HJ, Mornex F, Shaked A, Trotter JF.

Liver Transpl. 2011 Oct;17 Suppl 2:S159-61. doi: 10.1002/lt.22318. Review. No abstract available.

15.

Is the treatment of hepatocellular carcinoma on the waiting list necessary?

Majno P, Lencioni R, Mornex F, Girard N, Poon RT, Cherqui D.

Liver Transpl. 2011 Oct;17 Suppl 2:S98-108. doi: 10.1002/lt.22391. Review. No abstract available.

16.

Meta-analysis: evaluation of adjuvant therapy after curative liver resection for hepatocellular carcinoma.

Mathurin P, Raynard B, Dharancy S, Kirzin S, Fallik D, Pruvot FR, Roumilhac D, Canva V, Paris JC, Chaput JC, Naveau S.

Aliment Pharmacol Ther. 2003 May 15;17(10):1247-61. Review.

17.

Liver transplantation for hepatocellular carcinoma: an update.

Zarrinpar A, Kaldas F, Busuttil RW.

Hepatobiliary Pancreat Dis Int. 2011 Jun;10(3):234-42. Review.

PMID:
21669564
18.

Adjuvant treatment of hepatocellular carcinoma after orthotopic liver transplantation: do we really need this?

Fujiki M, Aucejo F, Kim R.

Clin Transplant. 2013 Mar-Apr;27(2):169-77. doi: 10.1111/ctr.12042. Epub 2012 Dec 6. Review.

PMID:
23216662
19.

Which matters most: number of tumors, size of the largest tumor, or total tumor volume?

Germani G, Gurusamy K, Garcovich M, Toso C, Fede G, Hemming A, Suh KS, Weber A, Burroughs AK.

Liver Transpl. 2011 Oct;17 Suppl 2:S58-66. doi: 10.1002/lt.22336. Review. No abstract available.

20.

Hepatocellular carcinoma: agents and concepts for preventing recurrence after curative treatment.

Schlitt HJ, Schnitzbauer AA.

Liver Transpl. 2011 Nov;17 Suppl 3:S10-2. doi: 10.1002/lt.22411. Review.

Supplemental Content

Support Center